SPOTLIGHT: Aussie docs ask pharma to fund staff

Staffing shortfalls at Sydney's Liverpool Hospital are so acute that senior doctors have been lobbying pharma companies for funds to recruit workers; one neurosurgeon asked an unnamed drug maker for $20,000 to pay for an administrative assistant, saying the practice was "widespread." Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.